Quantcast
Home > Quotes > VRML
VRML

Vermillion, Inc. Common Stock (VRML) Quote & Summary Data

$0.76
*  
0.02
2.56%
Get VRML Alerts
*Delayed - data as of Jul. 23, 2019  -  Find a broker to begin trading VRML now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    VRML After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 0.45 / $ 0.85
1 Year Target
Today's High / Low
$ 0.8062 / $ 0.7362
Share Volume
180,559
50 Day Avg. Daily Volume
190,981
Previous Close
$ 0.78
52 Week High / Low
$ 1.57 / $ 0.2701
Market Cap
73,864,932
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.12

Intraday Chart

Shares Traded

Share Volume:
180,559
50 Day Avg. Daily Volume:
190,981

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
Earnings Per Share (EPS):
$ -0.17

Trading Range

The current last sale of $0.76 is 181.38% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 0.8062 $ 1.57
 Low: $ 0.7362 $ 0.2701

Company Description (as filed with the SEC)

Corporate Vision: To drive the advancement of women's health by providing innovative methods to detect, monitor and manage the treatment of both benign and malignant gynecologic disease, with our primary focus being diseases of the female pelvic cavity. Our corporate strategy is to serve as a diagnostic service and bio-analytic solutions provider. Our plan is to broaden our commercial focus from ovarian cancer to differential diagnosis of women with a range of gynecological disorders. We are currently in the market expansion and growth phase of our strategy having added to our direct sales force in late 2018 and into the first quarter of 2019. We expanded our commercial strategy in 2018 through the establishment of medical and advisory support and a Key Opinion Leader Network aligned with our territories in the US.  ... More ...  



Risk Grade

Where does VRML fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 0.7916
Open Date:
Jul. 23, 2019
Close Price:
$ 0.7504
Close Date:
Jul. 23, 2019


Consensus Recommendation

Analyst Info